D.E. Shaw & Co’s BioLife Solutions BLFS Stock Holding History

D.E. Shaw & Co’s Portfolio BLFS Stock Details BLFS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$349K	Sell	12,349 -89,521	-88%	-$2.09M	﹤0.01%	4347
2026 Q1	$1.94M	Sell	101,870 -64,511	-39%	-$1.43M	﹤0.01%	2939
2025 Q4	$4.02M	Sell	166,381 -119,162	-42%	-$3.12M	﹤0.01%	2490
2025 Q3	$7.28M	Buy	285,543 +169,831	+147%	+$4.03M	﹤0.01%	1906
2025 Q2	$2.49M	Buy	+115,712	New	+$2.61M	﹤0.01%	2579
2021 Q2	–	Sell	-47,657	Closed	-$1.72M	–	4753
2021 Q1	$1.72M	Sell	47,657 -72,194	-60%	-$2.85M	﹤0.01%	2717
2020 Q4	$4.78M	Buy	119,851 +77,467	+183%	+$2.64M	﹤0.01%	1913
2020 Q3	$1.23M	Buy	+42,384	New	+$915K	﹤0.01%	2730

Other funds holding BLFS

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

D.E. Shaw & Co's BLFS Position: Q2 2026 in Review

D.E. Shaw & Co reduced its BioLife Solutions (BLFS) stake by 88% in Q2 2026, selling an estimated $2.09M and leaving 12,349 shares worth $349K. The position accounts for ﹤0.01% of the portfolio, ranked #4347.

D.E. Shaw & Co first reported a position in BLFS in Q3 2020 and has held it in 8 quarters since. The position peaked at $7.28M in Q3 2025. 216 funds tracked by Wall St. Rank hold BLFS as of Q2 2026.

D.E. Shaw & Co held 12,349 shares of BioLife Solutions worth $349K as of Q2 2026.
D.E. Shaw & Co sold 89,521 BioLife Solutions shares in Q2 2026, an estimated $2.09M.
BioLife Solutions made up ﹤0.01% of D.E. Shaw & Co's portfolio in Q2 2026, its #4347 holding.
D.E. Shaw & Co first reported a position in BioLife Solutions in Q3 2020 and has held it in 8 quarters since.
D.E. Shaw & Co's BioLife Solutions position peaked at $7.28M in Q3 2025.
216 funds tracked by Wall St. Rank held BioLife Solutions as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.